Figure 2.
Onset of all immune‐related adverse events (irAEs) by treatment cycle. Eighty‐eight patients had a total of 179 irAEs of any grade; 16 were recurrences of the same irAE on subsequent cycles after complete resolution.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.